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ABSTRACT 
An efficient synthesis of dihydropyrido[2,3-d:5,6-d`]pyrimidine derivatives was developed via one-pot three-component 
reaction of 6-amino-2-(alkylthio)-pyrimidine-4(3H)one and aryl aldehydes in the mixed solvent of glacial acetic acid and 
DMF (1:1, v:v) under ultrasonic irradiation. In this protocol novel fused dihydropyrido[2,3-d]pyrimidines were synthesized in 
high yields (80-97%) and  lower reaction times (5-25 min). 
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INTRODUCTION  
Pyridopyrimidines, their oxo and thioxo derivatives have been recognized as important organic materials in drug design, 
and showing interesting biological activities.  For example they are known to be inhibitors of tyrosine kinase of the 
epidermal growth factor receptor family [1],  antiviral [2], antioxidant [3] and antitumor [4]. Among them, pyrimido[4,5-
d]pyrimidines and pyrimido[2,3-d]pyrimidines, have been known to display a wide range of pharmacological activities [5,6]. 
It is well known that many pyrido[2,3-d]pyrimidine derivatives possess interesting biological logical properties. It has been 
proven that they possess diuretic [7], antibacterial [8], analgesic, anti-inflammatory [9], antiviral [10], anticonvulsive [11,12], 
antipyretic [13], cardiotonic [14, 15], antitumoral [16], bactericidal [17], bronchiodilator [18], antihistaminic [19], and other 
activities [20]. As a result, compounds of this class present considerable interest for research. Considering the important 
biological properties of fused pyrimidines, a number of methods have been reported for the synthesis of these 
heterocycles [21-28]. Some of these methods, suffer from one or more disadvantages such as using costly reagents, toxic 
catalysts and solvents, low yielding of products, harsh reaction conditions, and require prolonged heating and tedious 
work. As a result, development of a simple and green protocol for the synthesis of pyrido[2,3-d]pyrimidines is highly 
required. 
On the other hand green chemistry has become a major driving force for organic chemists to develop eco-friendly routes 
for the synthesis of organic compounds.  For example, the possibility of performing reactions under ultrasound irradiations. 
ultrasonic reactions have been increasingly used as green, clean and environmentally benign routes for the preparation of 
organic compounds [29-34]. A large number of organic reactions can be carried out in higher yield, shorter reaction time 
and under milder conditions, by using ultrasonic irradiation [35-38].  
These abservations led us to attempt the synthesis of some novel pyridodipyrimidine derivatives using 6-amino-2-
(alkylthio)pyrimidin-4(3H)-one under ultrasonic irradiations. 
RESULTS AND DISCUSSION 
In continuation of our ongoing program aiming to develop efficient and eco-friendly methods for the synthesis of biologically important 
heterocyclic compounds [39-42], we carried out a simple one-pot three-component reaction reaction for the synthesis of 
dihydropyridopyrimidines under ultrasonic irradiation. In this protocol the reaction of 6-amino-2-(alkylthio)pyrimidin-4(3H)-one  and 
arylaldehydes was studied in the mixed solvent of glacial acetic acide and DMF (1:1, v:v) under ultrasonic irradiation (Scheme 1). The 























Scheme 1: Synthesis of pyrido[2,3-d]pyrimidine derivatives (3a-v). 
In the initial experiments, different solvents and catalysts screened for the synthesis of dihydropyridopyrimine derivatives 
(3a-v). To optimize the reaction conditions, preparation of 5-(4-chlorophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-
d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione) (3a) by the reaction of 6-amino-2-(ethylthio)pyrimidin-4(3H)-one (2 mmol) and 4-
chlorobenzaldehyde (1 mmol) was selected as a model reaction. The results are summarized in Table 1. It is evident from 
the results that AcOH/DMF (1:1, v:v) is the most effective reaction medium among the solvents and catalysts selected, 
resulting in the highest yield (97 %) and the shortest reaction time (10 min) at 80 
o
C. For comparison the preparation of 3a 
was carried out under conventional heating at reflux temperature which furnished the product at lower yield and much 
higher reaction time (Table 1, entry 1). 
Table 1. Effect of various catalysts and solvents in the synthesis of 3a. 





  Time (min) Yield
c
 (%) Time (min) Yield
c
 (%) 
1 AcOH/DMF (1:1) 120 76 10 97 
2 AcOH/DMF (1:2) 120 70 13 92 
3 P-TSA/EtOH 180 72 15 85 
4 AcOH 210 75 15 87 
5 AcOH/EtOH (1:1) 220 72 20 80 
6 Ethylene glycol 210 60 25 70 
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To optimize the reaction condition under ultrasonic irradiations, we verified different temperature for the preparation of 
3a and the best result was obtained at 80 
o
C (Table 2). 





 Time (min) Yield
 
(%) 
1 25 40 60 
2 60 15 83 
3 80 10 97 
a
Ultrasonic irradiations. 
The starting material 1 was synthesized by condensation of thiourea with ethylcyanoacetate in sodium ethoxide and 
followed by alkylation with alkyl iodide according to the known procedure [43]. By using the optimized reaction conditions 
several derivatives of dihydropyridopyrimines (3a-v) were prepared in high to excellent yields ( 80-97%) and lower reaction 




C NMR) and 
elemental analyses. 
Table 3. Synthesis of 3a-v under optimized conditions. 
Entry Product R Ar Sonochemical method 
    Time (min) Yield 
a
 (%) 










3 3c SMe 2-ClC6H4 10 87 
4 3d SMe 2,4-Cl2C6H3 8 92 
5 3e SMe 4-FC6H4 6 93 
6 3f SMe 4-MeOC6H4 15 85 
7 3g SMe 4-O2NC6H4 10 90 










10 3j SMe 3-HOC6H4 5 95 
11 3k SMe 4-ClC6H4 6 97 




















16 3p SEt 4-CF3C6H4 10 (120) 82 (79) 
17 3q SEt 2-FC6H4 15 (140) 85 (78) 
18 3r SEt 2-BrC6H4 15 (140) 85 (77) 
19 3s SEt 4-OMeC6H4 20 (160) 85 (75) 
20 3t SEt 4-CHOC6H5 14 (155) 83 (77) 
21 3u SEt 2-naphtyl 22 76 
22 3v SEt C6H5 25 77 
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a
 Isolated Yield. 
b
 Conventional heating in refluxing AcOH/DMF (1:1). 
The plausible mechanism of the formation of 3a-v is outlined in Scheme 2. Due to the protonation of aldehyde by AcOH, 
aldehyde becomes a strong electrophile in reaction with 1. The high reactivity of enamine 1 allows the addition of this 
molecule to the protonated aldehyde through a Knoevenagel condensation and producing the arylidene intermediate 5 by 
loss of H2O. Finally  Michael addition of second molecule of enamine 1 to the intermediate 5 and loss of NH3 furnishes 
the desired dihydropyridodipyrimidines 4 (Scheme 2). 
 
 
Scheme 2: Plausible mechanism for the synthesis of (3a-v). 
EXPERIMENTAL 
Melting points were recorded on a Büchi B-545 apparatus in open capillary tubes. IR spectra were determined on a 
Shimadzo IR-470 spectrometer. 
1
H NMR and 
13
C NMR spectra were recorded on a 400 MHz Bruker DRX-400 and 
DMSO-d6 as solvent and TMS as an internal standard. Elemental analyses were done on a Carlo-Erba EA1110CNNO-S 
analyzer and agreed with the calculated values. Chemicals were purchased from Merck and Fluka.  All solvents used were 
dried and distilled according to standard procedures. 
General procedure for preparation of (3a-v) 
A mixture of 6-amino-2-(alkylthio)pyrimidin-4(3H)-one (2 mmol) and aldehyde (1 mmol) in AcOH/DMF(1:1, v:v) (6 mL) was 
heated under reflux or by ultrasonic irradiations using Elmasonic S-40H ultrasonic cleaning unit at 80 
o
C (under silent 
condition). The progress of the reaction was monitored by TLC (EtOAc/hexane/methanol 8:3:1). After completion of the 
reaction, the mixture was poured into ice-water, the solid obtained was filtered off, washed by THF and recrystalyzed from 
DMF/ H2O to furnish the desired pure products. 
5-(4-Chlorophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3a). White 




: 3354; 3180; 3033; 2967; 2933; 2866; 1653; 1610; 1558; 1446; 1446; 1335; 1236; 1094; 
831. 
1
H NMR (DMSO-d6), δ: 1.31 (t, J = 6.9 Hz, 6H, CH3); 3.11 (q, 4H, CH2, J = 6.9 Hz); 5.45 (s, 1H, CH); 6.82 (br. s, 1H, 
NH); 7.04 (d, 2H, Ar-H, J = 8.0 Hz); 7.26 (d, 2H, Ar-H, J = 8.0 Hz); 11.98 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 
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15.2; 24.3; 33.5; 92.7; 128.0; 129.0; 129.8; 138.8; 158.3; 161.9; 163.8.  Anal. Cald. for  C19H18ClN5O2S2 (447.96). 
Calculated (%): C, 50.94; H, 4.05; N, 15.63; Found (%): C, 50.86; H, 4.16; N, 15.79. 
 
5-(3-Hydroxyphenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dion (3b). White 




: 3441; 3340; 3155; 2968; 2926; 2862; 1647; 1616;1558; 1452;1452; 1367; 1230; 878; 
812; 698. 
1
H NMR (DMSO-d6),  δ: 1.31 (t, 6H, CH3, J = 7.0 Hz); 3.11 (q, 4H, CH2, J = 7.0 Hz); 5.41 (s, 1H, CH); 6.50 (m, 
3H, Ar-H); 6.78 (br. s, 1H, NH); 6.98 (t, 1H, Ar-H, J = 7.6 Hz); 9.0 (s, 1H, OH); 11.93 (br. s, 2H, NH-C=O) . 
13
C NMR 
(DMSO-d6),  δC: 15.2; 24.3; 33.8; 112.2; 112.3; 113.9; 114.0; 117.9; 128.9; 141.4; 157.3; 157.4; 157.8. Anal. Cald. for  
C19H19N5O3S2 (429.52). Calculated (%):  C, 53.13; H, 4.46; N, 16.31; Found (%): C, 53.00; H, 4.59; N, 16.18. 
5-(2-Chlorophenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3c). White 




: 3427; 3209; 3112; 2923; 1649; 1608; 1537; 1431; 1344; 1238; 1033; 771; 739. 
1
H 
NMR (DMSO-d6), δ: 2.47 (s, 6H, CH3); 5.42 (s, 1H, CH); 6.88 (br.s, 1H, NH); 7.27-7.13 (m, 4H, Ar-H); 11.94 (br. s, 2H, 
NH-C=O). 
13
C NMR (DMSO-d6), δC: 12.9; 33.3; 110.8; 126.8; 127.4; 127.5; 129.3; 129.6; 133.1; 138.7; 158.6; 161.5. 
Anal. Cald. for  C17H14ClN5O2S2 (419.91). Calculated (%): C, 48.63; H, 3.36; N, 16.68; Found, %: C, 48.50; H, 3.16; N, 
16.49. 
5-(2,4-Dichlorophenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3d). White 
powder, m.p. > 300 
o
C. IR spectrum, ν/cm
–1
: 3360; 3200; 3009; 2926; 2813; 1658; 1607; 1577; 1539; 1437; 1437; 1340; 
1236; 1099; 1043; 890; 808; 758. 
1
H NMR (DMSO-d6), δ: 2.47 (s, 6H, CH3); 5.38 (s, 1H, CH); 6.94 (br. s, 1H, NH); 7.21 (d, 
1H, Ar-H, J = 8.8 Hz); 7.32 (dd, 2.1 Hz, 1H, Ar-H, J = 8.6 Hz); 7.41 (d, 1H, Ar-H, J = 2.0 Hz); 12.00 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 12.9; 33.0; 92.3; 127.0; 129.0; 130.6; 131.0; 133.9; 138.0; 158.9; 161.4, 161.5; 161.6; 163.2.  
Anal. Cald. for  C17H13Cl2N5O2S2 (454.36). Calculated (%): C, 44.94; H, 2.88; N, 15.41; Found (%): C, 44.82; H, 2.97; N, 
15.25. 
5-(4-Fluorophenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3e). White 




: 3456; 3292; 3163; 3090; 2999; 2922; 1645; 1614; 1577; 1450; 1450; 1335; 1234; 1155; 
846.
 1
H NMR (DMSO-d6), δ: 2.48 (s, 6H, CH3); 5.44 (s, 1H, CH); 6.81 (br.s, 1H, NH); 7.05-6.98 (m, 4H, Ar-H); 12.01 (br. s, 
2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 12.9; 33.3; 92.9; 114.6 (d, 
2
JC-F = 21.0 Hz); 128.7 (d, 
3
JC-F = 8.0 Hz); 135.5 (d, 
4
JC-
F = 2.0 Hz); 158.8; 160.6 (d, 
1
JC-F = 239.0 Hz); 163.7. Anal. Cald. for C17H14FN5O2S2 (403.45). Calculated (%): C, 50.61; H, 
3.50; N, 17.36; Found (%): C, 50.48; H, 3.55; N, 17.47. 
5-(4-Methoxyphenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dion (3f). White 




: 3400; 3312; 3180; 3080; 2995; 2926; 1633; 1610; 1577; 1541; 1512; 1442; 1442; 1338; 
1240; 1034; 831. 
1
H NMR (DMSO-d6),  δ: 2.48 (s, 6H, CH3); 3.71 (s, 3H, OCH3); 5.42 (s,1H, CH); 6.77 (d, 2H, Ar-H, J = 
8.4 Hz); 6.92 (d, 2H, Ar-H, J = 8.4 Hz); 7.26 (br. s, 1H, NH); 11.96 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC:
 
12.9; 
33.2; 55.3; 93.3; 113.5;128.0; 131.3; 157.3; 158.6; 161.9; 163.7. Anal. Cald. for Calculated (%): C, 52.03; H, 4.12; N, 
16.86; Found (%): C, 52.20; H, 4.02; N, 16.98. C18H17N5O3S2 (415.49). 
5-(4-Nitrophenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3g). White 




: 3447; 3300; 3188; 2928; 2851; 1642; 1610; 1533; 1515; 1438; 1515; 1342; 1438; 1342; 
1236; 844. 
1
H NMR (DMSO-d6), δ: 2.49 (s, 6H, CH3); 5.54 (s, 1H, CH); 6.91 (br. s, 1H, NH); 7.29 (d, 2H, Ar-H, J = 8.8 Hz); 
8.10 (d, 2H, Ar-H, J = 8.8 Hz); 12.08 (s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 12.9;  34.4; 92.4; 123.4; 128.4; 145.7; 
149.0; 159.2; 163.0. Anal. Cald. for C17H14N6O4S2 (430.46). Calculated (%):  C, 47.43; H, 3.28; N, 19.52; Found (%): C, 
47.58; H, 3.12; N, 19.41.   
5-(3-Nitrophenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3h). White 




: 3355; 3198; 2923; 2850; 1658; 1606; 1528; 1434; 1523; 1342; 1342; 1238; 831.  
1
H 
NMR (DMSO-d6), δ: 2.50 (s, 6H, CH3); 5.56 (s, 1H, CH); 6.94 (br. s, 1H, NH); 7.55-7.47 (m, 2H, Ar-H); 7.80 (dd, 1H, Ar-H, 
J1 = 3.2 Hz, J2 = 2.0 Hz); 8.03-8.00 (m, 1H, Ar-H); 12.11 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 12.9; 33.9; 92.4; 
120.8; 121.7; 129.6; 134.3; 142.5; 148.2; 159.2; 163.0. C17H14N6O4S2 (430.46). Anal. Cald. for Calculated (%):  C, 47.43; 
H, 3.28; N, 19.52; Found (%): C, 47.31; H, 3.39; N, 19.32. 





: 3448; 3290; 3159; 3084; 2997; 2916; 2878; 1641; 1610; 1578; 1531; 1450; 1450; 1326; 1236; 771; 
692. 
1
H NMR (DMSO-d6), δ: 2.48 (s, 6H, CH3); 5.47 (s, 1H, CH); 6.08 (br. s, 1H, NH); 7.02 (d, 2H, Ar-H, J = 8.4 Hz); 7.1 
(dt, 1H, Ar-H, J1 = 7.3, J2 = 1.0 Hz); 7.20 (t, 2H, Ar-H, J = 7.4 Hz);11.98 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 
12.9; 33.9; 93.0; 125.3; 127.0; 128.1; 139.7; 158.1; 161.2; 163.0. Anal. Cald. for C17H15N5O2S2 (385.46). Calculated (%):  
C, 52.97; H, 3.92; N, 18.17; Found (%): C, 52.81; H, 3.98; N, 18.05. 
5-(3-Hydroxyphenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3j). White 




: 3446; 3294; 3178; 3088; 2995; 2920; 2891; 1641; 1606; 1577; 1448; 1448; 1336; 1234; 
820; 783; 690. 
1
H NMR (DMSO-d6), δ: 2.43 (s, 6H, CH3); 5.37 (s, 1H, CH); 6.43(m, 3H, Ar-H); 6.73 (br. s, 1H, NH); 6.93 (t, 
1H, Ar-H, J = 7.58 Hz); 8.92 (br. s, 1H, OH); 11.90 (br. s, NH-C=O). 
13
C NMR (DMSO-d6), δC: 12.9; 33.8; 112.2; 113.8; 
113.9; 117.9; 128.9; 141.4; 157.3; 157.4; 158.6; 162.8. Anal. Cald. for C17H15N5O3S2 (401.46). Calculated (%):  C, 50.86; 
H, 3.77; N, 17.44; Found (%): C, 50.60; H, 3.64; N, 17.35. 
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5-(4-Chlorophenyl)-2,8-bis(methylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3k). White 




: 3445; 3391; 3306; 3173; 3091; 2923; 1635; 1608; 1577; 1539;  1442; 1442; 1336; 
1240; 1091; 829. 
1
H NMR (DMSO-d6), δ: 2.43 (s, 6H, CH3); 5.40 (s, 1H, CH); 6.76 (br. s, 1H, NH); 6.99 (d, 2H, Ar-H, J = 
8.32 Hz); 7.22 (d, 2H, Ar-H, J = 8.32 Hz); 11.96 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 12.9; 33.6; 92.7; 128.0; 
129.0; 129.8; 138.9; 159.0; 162.3; 163.8. Anal. Cald. for C17H14ClN5O2S2 (419.91). Calculated (%):  C, 48.63; H, 3.36; N, 
16.68; Found (%): C, 48.68; H, 3.25; N, 16.52. 
5-(2,4-Dichlorophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3l). White 




: 3360; 3205; 2963; 2924; 2880; 1655; 1605; 1558; 1441; 1441; 1370; 1240; 1133; 1043; 
874; 690. 
1
H NMR (DMSO-d6), δ: 1.30 (t, 6H, CH3, J = 7.4 Hz); 3.10 (q, 4H, CH2, J = 7.4 Hz); 5.39 (s, 1H, CH); 6.89 (br. s, 
1H, NH); 7.22 (d, 1H, Ar-H, J = 8.4 Hz); 7.35 (dd, 1H, Ar-H, J1 = 8.4 Hz, J2 = 2.4 Hz); 7.42 (d, 1H, Ar-H, J = 2.4 Hz); 11.88 
(br. s, 1H, NH-C=O); 12.07 (br. s, 1H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 15.1; 24.3; 33.0; 127.0; 129.0; 130.6; 131.0; 
133.9; 138.0; 158.2; 161.5. Anal. Cald. for  C19H17Cl2N5O2S2 (482.41). Calculated (%):  C, 47.31; H, 3.55; N, 14.52; Found 
(%): C, 47.20; H, 3.64; N, 14.60. 
5-(4-Nitrophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3m). Cream 




: 3352; 3182; 2962; 2926; 2870; 1653; 1606; 1518; 1445; 1518; 1342; 1342; 1236; 845. 
1
H NMR (DMSO-d6), δ: 1.31 (t, 6H, CH3, J = 7.4 Hz); 3.12 (m, 4H, CH2); 5.55 (s, 1H, CH); 6.92 (br. s, 1H, NH); 7.30 (d, 
2H, Ar-H, J = 8.6 Hz); 8.11 (d, 2H, Ar-H, J = 8.6 Hz); 12.07 (s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 15.2; 24.3; 34.5; 
92.4; 123.4; 128.4; 145.7; 149.0; 158.6; 162.0; 163.9. Anal. Cald. for C19H18N6O4S2 (458.51). Calculated (%):  C, 49.77; H, 
3.96; N, 18.33; Found (%): C, 49.65; H, 3.84; N, 18.48. 
5-(4-Bromophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dion (3n). White 




: 3348; 3182; 2966; 2926; 2862; 1657; 1607; 1564; 1539; 1443; 1443; 1335; 1236; 1066; 
827. 
13
C NMR (DMSO-d6), δ:  15.2; 24.3; 33.6; 92.6; 118.3; 129.5; 130.9; 139.4; 158.3; 162.1; 163.8. C19H18BrN5O2S2 
(492.41). Anal. Cald. for Calculated (%):  C, 46.34; H, 3.68; N, 14.22; Found (%): C, 46.39; H, 3.52; N, 14.10. 
5-(2-Chlorophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3o). White 




: 3350; 3196; 2965; 2933; 1653; 1605; 1558; 1439; 1439; 1358; 1234; 1126; 1038, 779. 
1
H NMR (DMSO-d6), δ: 1.30 (t, 6H, CH3, J = 7.2 Hz); 3.11 (q, 4H, CH2, J = 7.2 Hz); 5.43 (s, 1H, CH); 7.24-7.17 (m, 3H, Ar-
H); 7.29 (d, 1H, Ar-H, J = 7.6 Hz); 11.96 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6),  δC: 15.1; 24.3; 33.3; 92.6; 126.9; 
127.5; 129.3; 129.6; 133.1; 138.7; 158.0; 161.6; 161.7. Anal. Cald. for C19H18ClN5O2S2 (447.96). Calculated (%):  C, 
50.94; H, 4.05; N, 15.63; Found (%): C, 50.76; H, 4.16; N, 15.44. 
5-(4-(Trifluoromethyl)phenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dion (3p). 




: 3348; 3184; 2960; 2940; 2867; 1653; 1610; 1541; 1448; 1448; 1327; 1163; 
1119; 1238; 841. 
1
H NMR (DMSO-d6),  δ: 1.31 (t, 6H, CH3, J = 7.4 Hz); 3.12 (m, 4H, CH2); 5.53 (s, 1H, CH); 6.86 (br. s, , 
1H, NH); 7.24 (d, 2H, Ar-H, J = 8.2 Hz); 7.57 (d, 2H, Ar-H, J = 8.2 Hz); 12.03 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), 
δC: 15.2;  24.3; 34.1; 92.6; 124.1 (d, 
1
JC-F = 270.0 Hz, CF3); 125.0 (q, 
3
JC-F = 3.0 Hz); 126.1 (q, 
2
JC-F = 31.0 Hz, C-CF3); 
127.8; 145.1; 158.5; 162.2; 163.9. Anal. Cald. for C20H18F3N5O2S2 (481.51). Calculated (%):  C, 49.89; H, 3.77; N, 14.54; 
Found (%): C, 49.75; H, 3.62; N, 14.39. 
5-(2-Fluorophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3q). White 




: 3362; 3198; 2963; 2923; 2873; 1653; 1608; 1533; 1510; 1439; 1439; 1343; 1228; 758. 
1
H NMR (DMSO-d6), δ: 1.30 (t, 6H, CH3, J = 7.2 Hz); 3.09 (q, 4H, CH2, J = 7.2 Hz); 5.48 (s, 1H, CH); 6.8 (br. s, 1H, NH); 
6.98 (dd, 1H, Ar-H, J1 = 11.2 Hz, J2 = 8.4 Hz); 7.07-7.05 (m, 2H, Ar-H); 7.19-7.17 (m, 1H, Ar-H), 11.95 (br. s, 2H, NH-
C=O). 
13
C NMR (DMSO-d6), δC: 15.2;  24.3; 29.8; 92.6; 115.0 (d, 
2
JC-F = 23.0 Hz); 124.0 (d, 
4
JC-F = 2.0 Hz); 127.5 (d, 
3
JC-F 
= 8.0 Hz); 127.6 (d, 
2
JC-F = 16.8 Hz); 128.9 (d, 
3
JC-F = 4.0 Hz); 158.0; 161.4; 161.5 (d, 
1
JC-F = 244.0 Hz); 163.6. 
C19H18FN5O2S2 (431.51). Anal. Cald. for Calculated (%):  C, 52.89; H, 4.20; N, 16.23; Found (%): C, 52.73; H, 4.08; N, 
16.21. 
5-(2-Bromophenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3r). White 




:3362; 3198; 2960; 2920; 2860; 1649; 1608; 1531; 1450; 1450; 1232; 800. 
1
H NMR 
(DMSO-d6), δ: 1.30 (t, J = 7.2 Hz, 6H, CH3); 3.11 (br.s, 4H, CH2); 5.35 (s, 1H, CH); 6.88 (s, br,1H, NH); 7.09-7.06 (m, 1H, 





15.1; 24.3; 35.5; 123.6; 127.4; 127.8; 129.5; 133.1; 140.4; 158.0; 158.1; 161.82; 161.84. 
C19H18BrN5O2S2 (492.41). Anal. Cald. for Calculated (%):  C, 46.34; H, 3.68; N, 14.22; Found (%): C, 46.25; H, 3.58; N, 
14.31. 
5-(4-Methoxyphenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dion (3s). White 




: 3350; 3178; 2959; 2946; 1649; 1606; 1578; 1539; 1512; 1441; 1441; 1335; 1240; 1034; 
833. 
1
H NMR (DMSO-d6), δ: 1.30 (t, 6H, CH3, J = 7.2 Hz); 3.10 (q, 4H, CH2, J = 7.2 Hz); 5.42 (s, 1H, CH); 3.71 (s, 3H, 
OCH3); 6.65 (br. s, 1H, NH); 6.77 (d, 2H, Ar-H, J = 8.6 Hz); 6.92 (d, 2H, Ar-H, J = 8.6 Hz); 11.93 (br. s, 2H, NH-C=O). 
13
C 
NMR (DMSO-d6), δC: 15.2; 24.3; 33.2; 55.3; 93.4; 113.5; 128.0; 131.4; 157.2; 158.0; 162.2; 163.8. Anal. Cald. for 
C20H21N5O3S2 (443.54). Calculated (%):  C, 54.16; H, 4.77; N, 15.79; Found (%): C, 54.03; H, 4.68; N, 15.70. 
5-(4-Formylphenyl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dion (3t). White 




: 3367; 3184; 2966; 2924; 1695; 1642; 1608; 1570; 1435; 1435; 1335; 1227, 831. 
1
H 
NMR (DMSO-d6), δ: 1.31 (t, J = 7.2 Hz, 6H, CH3); 3.13-3.10 (m, 4H, CH2); 5.53 (s, 1H, CH); 6.86 (br.s, 1H, NH); 7.25 (d, 
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2H, Ar-H, J = 8.0 Hz); 7.77 (d, 2H, Ar-H, J = 8.0 Hz); 9.94 (s, 1H, CHO); 12.02 (br.s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), 
δC: 15.2; 24.3; 34.5; 92.6; 123.5; 127.8; 129.6; 134.2; 193.1; 164.7; 158.5; 147.9. Anal. Cald. For C20H19N5O3S2 
(441.53).Calculated (%):  C, 54.41; H, 4.34; N, 15.86; Found (%): C, 54.58; H, 4.25; N, 15.71. 
5-(Naphthalen-2-yl)-2,8-bis(ethylthio)-5,10-dihydropyrido[2,3-d:5,6-d`]dipyrimidin-4,6(3H,7H)-dione (3u). White 




: 3350; 3184; 2950; 2926; 2858; 1653; 1608; 1533; 1443; 1443; 1329; 1238; 814; 739; 
708. 
1
H NMR (DMSO-d6), δ: 1.33 (t, J = 7.4 Hz, 6H, CH3); 3.14-3.12 (m, 4H, CH2); 5.63 (s, 1H, CH); 6.83 (br.s, 1H, NH); 
7.25 (d, 1H, Ar-H, J = 8.6 Hz); 7.43-7.41 (m, 2H, Ar-H); 7.46 (s, 1H, Ar-H); 7.74 (d, 1H, Ar-H, J = 8.6 Hz); 7.84-7.77 (m, 
2H, Ar-H ); 11.99 (br. s, 2H, NH-C=O). 
13
C NMR (DMSO-d6), δC: 15.2;  24.3; 34.2; 89.0; 124.0; 125.3; 126.0; 127.0; 127.4; 
127.6; 127.9; 128.8; 131.8; 133.5; 137.7; 139.0; 158.5. Anal. Cald. for C23H21N5O2S2 (463.58). Calculated (%):  C, 59.59; 
H, 4.57; N, 15.11; Found (%): C, 59.67; H, 4.62; N, 15.01. 





: 3360; 3302; 3194; 2972; 2924; 2862; 1610; 1568; 1539; 1443; 1443; 1373; 1238; 773; 694 . 
1
H NMR 
(DMSO-d6), δ: 1.31 (t, 6H, CH3, J = 7.0 Hz); 3.10 (q, 4H, CH2, J = 7.0 Hz); 5.48 (s, 1H, CH); 6.77 (br. s, 1H, NH); 7.03 (d, 
2H, Ar-H, J = 7.6 Hz); 7.1 (t, 1H, Ar-H, J = 7.0 Hz); 7.20 (t, 2H, Ar-H, J = 7.4 Hz); 11.82 (br. s, 2H, NH-C=O). 
13
C NMR 
(DMSO-d6), δC: 15.2;  24.3; 33.9; 93.0; 125.3; 127.0; 139.8; 128.0; 158.1; 161.2; 162.8. Anal. Cald. for C19H19N5O2S2 
(413.52). Calculated (%):  C, 55.19; H, 4.63; N, 16.94; Found (%): C, 55.10; H, 4.78; N, 16.75. 
CONCLUSION 
In summary, we have developed a simple and efficient protocol for the synthesis of new derivatives of 
dihydropyridodipyrimidines in the mixed solvent of glacial acetic acid and DMF (1:1, v:v) under ultrasonic irradiation.  The 
reaction induced by ultrasound offered better yields and much lower reaction times than the conventional heating.  The 
easy work of the products, mild reaction condition and cleaner reaction are the notable features of this protocol.
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